⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVMD News
Revolution Medicines, Inc. Common Stock
Form 8-K
sec.gov
RVMDW
RVMD
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
globenewswire.com
RVMD
Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference
globenewswire.com
RVMD
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026
globenewswire.com
RVMD
Molecular Glues Competitive Landscape Research Report 2026: Comprehensive Insights About 80+ Companies and 90+ Drugs
globenewswire.com
BMY
RVMD
NRIX
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
globenewswire.com
RVMD
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
globenewswire.com
RVMD
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib
globenewswire.com
RVMD
Glabellar Frown Lines Market Analysis and Demand Forecast, 2025-2035, with Regional Insights
globenewswire.com
ABBV
RVMD
Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RVMD